Home » Authors » Karthick Vishwanathan, Inmaculada Sanchez-Simon, Bhumsuk Keam, Nicolas Penel, Maria de Miguel-Luken, Doris Weilert, Andrew Mills, Marcelo Marotti, Alain Ravaud

Karthick Vishwanathan, Inmaculada Sanchez-Simon, Bhumsuk Keam, Nicolas Penel, Maria de Miguel-Luken, Doris Weilert, Andrew Mills, Marcelo Marotti, Alain Ravaud

Public reference bibliography and cataloged PDF materials authored or published by Karthick Vishwanathan, Inmaculada Sanchez-Simon, Bhumsuk Keam, Nicolas Penel, Maria de Miguel-Luken, Doris Weilert, Andrew Mills, Marcelo Marotti, Alain Ravaud.

Found 1 document(s) Page 1 of 1

A multicenter, phase I, pharmacokinetic study of osimertinib in cancer patients with normal renal function or severe renal impairment.

Year: 2020 • Source: hal.science • Listed PDF

Osimertinib is a third-generation, irreversible, oral epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor (TKI) that potently and selectively inhibits both EGFR-TKI sensitizing and EGFR T790M and has demons...